- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04951258
Multicomponent Exercise in People With Dementia
August 21, 2021 updated by: Yea-Ru Yang, National Yang Ming University
Effect of Multicomponent Exercise on Cognitive Function and Activities of Daily Living in People With Dementia
People with dementia shows a decline in cognition, such as memory, executive function (EF), language, attention, and spatial orientation that is significant enough to interfere with the independence and daily functioning.
Previous studies reported that multicomponent exercise improved EF in people with mild cognitive impairment and independence of ADL in those with Alzheimer's disease.
However, few studies investigated whether multicomponent exercise improved EF, memory, and ADL in people with dementia.
Therefore, the purposes of this study are to examine 1) the effect of multicomponent exercise on EF, memory, and ADL in people with mild to moderate dementia; 2) the correlation between change in EF and ADL; 3) the correlation between change in memory and ADL.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yea-Ru Yang, Professor
- Phone Number: +886-2-28267279
- Email: yryang@nycu.edu.tw
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age: 60-80 y/o
- Mini-Mental State Examination: 10-26
- Clinical Dementia Rating: 1-2
- Walk at least 6 meters independently (with or without walking aids)
Exclusion Criteria:
- Any other diagnosis of neurological diseases or musculoskeletal problems (Except dementia)
- Physical or psychological comorbidities that affect performance during assessment or intervention
- Already participating in other physical training in the last 1 month
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Multicomponent exercise group
|
The intervention is a 60-minute session, 3 times/week, totaling 9 weeks.
Multicomponent exercise included strengthening, balance training, aerobic dance, and stretching
|
Active Comparator: Video home exercise group
|
The intervention is a 60-minute session, 3 times/week, totaling 9 weeks.
Video home exercise included four limbs mobility exercise, stretching, strengthening, and aerobic exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mini-Mental State Examination
Time Frame: Change from baseline at 9 week
|
It is a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment.
Higher scores mean a better outcome.
|
Change from baseline at 9 week
|
Chinese version of Verbal learning test
Time Frame: Change from baseline at 9 week
|
It is a 9-point measurement to evaluate memory.
Higher scores mean a better outcome.
|
Change from baseline at 9 week
|
Chinese version of Stroop color and word test
Time Frame: Change from baseline at 9 week
|
It is a measurement to evaluate inhibition control.
|
Change from baseline at 9 week
|
Digit span test
Time Frame: Change from baseline at 9 week
|
It is a measurement to evaluate working memory.
|
Change from baseline at 9 week
|
Trail making test - Chinese version
Time Frame: Change from baseline at 9 week
|
It is a measurement to evaluate cognitive flexibility.
|
Change from baseline at 9 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Barthel index
Time Frame: Change from baseline at 9 week
|
It is a 100-point ordinal scale used to measure performance in activities of daily living.
Higher scores mean a better outcome.
|
Change from baseline at 9 week
|
Instrumental activities of daily living (IADL) scale
Time Frame: Change from baseline at 9 week
|
It is a 24-point ordinal scale used to measure performance in instrumental activities of daily living.
Higher scores mean a better outcome.
|
Change from baseline at 9 week
|
Chinese version of Quality of Life in Alzheimer Disease Scale
Time Frame: Change from baseline at 9 week
|
It is a measurement to evaluate quality of life.
The scale scores range from 13 to 52, with higher scores indicating greater quality of life.
|
Change from baseline at 9 week
|
Time up and go test
Time Frame: Change from baseline at 9 week
|
It is a test to evaluate functional mobility.
|
Change from baseline at 9 week
|
30-second chair stand test
Time Frame: Change from baseline at 9 week
|
It is a test to evaluate muscle strength.
|
Change from baseline at 9 week
|
6-minute walk test
Time Frame: Change from baseline at 9 week
|
It is a test to evaluate endurance.
|
Change from baseline at 9 week
|
Berg Balance Scale
Time Frame: Change from baseline at 9 week
|
It is a tool to evaluate balance.
It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function.
|
Change from baseline at 9 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 1, 2021
Primary Completion (Anticipated)
December 31, 2022
Study Completion (Anticipated)
December 31, 2022
Study Registration Dates
First Submitted
June 18, 2021
First Submitted That Met QC Criteria
June 25, 2021
First Posted (Actual)
July 6, 2021
Study Record Updates
Last Update Posted (Actual)
August 24, 2021
Last Update Submitted That Met QC Criteria
August 21, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YM110062F
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden
Clinical Trials on Multicomponent exercise
-
Fundacion Miguel ServetRecruitingCancer | Aging | Hospital Acquired Condition | DebilitySpain
-
Universitat Internacional de CatalunyaUnknownBone Diseases | Exercise | Osteoporosis | Osteoporosis, Postmenopausal
-
Fundacion Miguel ServetUniversidad Pública de Navarra; Complejo Hospitalario de NavarraCompletedFrailty | Disability Physical | Hospital Acquired ConditionSpain
-
Universidade Federal de Sao CarlosCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.Completed
-
University of SalamancaNot yet recruitingExercise | Aging
-
National University Hospital, SingaporeNational Medical Research Council (NMRC), SingaporeUnknownFrail Elderly Syndrome
-
Hong Kong Baptist UniversityRecruitingDepressive SymptomsHong Kong
-
University of SevilleCompletedGait | Physical Therapy | Sports Physical Therapy | Exercise TherapySpain
-
National Yang Ming UniversityUnknown
-
University of South CarolinaCenters for Disease Control and PreventionCompletedArthritis | Osteoarthritis | Rheumatoid Arthritis | FibromyalgiaUnited States